Skip to main content

Advertisement

Table 2 Prevalence of cytomegalovirus (CMV) in patients with inflammatory bowel disease and healthy controls

From: The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central China

     IBD    UC   CD Healthy controls
   (n = 226)  (n = 189)  (n = 37)    (n = 290)
CMV detection n (%) n (%) n (%) n (%)
DNA DNA+ 90 (84.07)a 161 (85.19)d 29 (78.38)g 173 (59.66)
Serum CMV IgG+ 172 (76.11)b 139 (73.54)e 33 (89.19)h 147 (50.69)
Serum CMV IgM+ 4 (1.77)c 3 (1.59)f 1 (2.70)i 1 (0.34)
  1. a Compare with healthy controls, OR = 3.569, 95% CI: 2.330-5.468, P < 0.001;
  2. b Compare with healthy controls, OR = 3.099, 95% CI: 2.113-4.543, P < 0.001;
  3. c Compare with healthy controls, OR = 5.207, 95% CI: 0.578-46.914, P = 0.235;
  4. d Compare with healthy controls, OR = 3.889, 95% CI:2.443-6.190, P < 0.001;
  5. e Compare with healthy controls, OR = 2.704, 95% CI:1.819-4.022, P < 0.001;
  6. f Compare with healthy controls, OR = 4.661, 95% CI:0.481-45.148, P = 0.344;
  7. g Compare with healthy controls, OR = 2.452, 95% CI:1.083-5.550, P = 0.027;
  8. h Compare with healthy controls, OR = 8.026, 95% CI:2.772-23.232, P < 0.001;
  9. i Compare with healthy controls, OR = 8.028, 95% CI:0.491-131.142, P = 0.540.
  10. IBD, inflammatory bowel disease; CMV, cytomegalovirus; UC, ulcerative colitis; CD, Crohn’s disease.